Snatch This Deal Even Lower Than Chief Executive Officer Zanganeh Did
April 17, 2024 at 11:11 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 27, Summit Therapeutics Inc's Chief Executive Officer, Mahkam Zanganeh, invested $411,094.12 into 110,321 shares of SMMT, for a cost per share of $3.73..